GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nova Leap Health Corp (OTCPK:NVLPF) » Definitions » EV-to-EBITDA

Nova Leap Health (Nova Leap Health) EV-to-EBITDA : -101.84 (As of May. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nova Leap Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nova Leap Health's enterprise value is $17.42 Mil. Nova Leap Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.17 Mil. Therefore, Nova Leap Health's EV-to-EBITDA for today is -101.84.

The historical rank and industry rank for Nova Leap Health's EV-to-EBITDA or its related term are showing as below:

NVLPF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -5752.2   Med: 11.59   Max: 202.09
Current: -101.84

During the past 7 years, the highest EV-to-EBITDA of Nova Leap Health was 202.09. The lowest was -5752.20. And the median was 11.59.

NVLPF's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 13.01 vs NVLPF: -101.84

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-14), Nova Leap Health's stock price is $0.20. Nova Leap Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.013. Therefore, Nova Leap Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Nova Leap Health EV-to-EBITDA Historical Data

The historical data trend for Nova Leap Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Leap Health EV-to-EBITDA Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial -61.54 189.43 37.37 11.31 44.15

Nova Leap Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.22 44.15 40.57 109.36 -69.84

Competitive Comparison of Nova Leap Health's EV-to-EBITDA

For the Medical Care Facilities subindustry, Nova Leap Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Leap Health's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's EV-to-EBITDA falls into.



Nova Leap Health EV-to-EBITDA Calculation

Nova Leap Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=17.415/-0.171
=-101.84

Nova Leap Health's current Enterprise Value is $17.42 Mil.
Nova Leap Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nova Leap Health  (OTCPK:NVLPF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nova Leap Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.20/-0.013
=At Loss

Nova Leap Health's share price for today is $0.20.
Nova Leap Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.013.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Nova Leap Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nova Leap Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Leap Health (Nova Leap Health) Business Description

Traded in Other Exchanges
Address
7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of personal home care and support services. The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offering includes meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S operations. The company derives a majority of its revenue from the United States.